Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongwei Li

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
Molecular Cancer Therapeutics|November 3, 2019
Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Molecular Cancer Therapeutics|April 20, 2013
DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphomaDongwei Li, Kirsten Achilles Poon, Shang-Fan Yu, et al.
The Journal of Biological Chemistry|July 26, 2019
Vitamin C-dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transitionTian Zhang, Ke Huang, Yanling Zhu, et al.
Nature Biotechnology|January 24, 2012
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesBen-Quan Shen, Keyang Xu, Luna Liu, et al.
Nature|June 17, 2026
Spatial distribution of the proteome in the human body and in cancersLiang Yue, Wenhao Jiang, Sainan Li, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
Molecular Cancer Therapeutics|November 3, 2019
Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Molecular Cancer Therapeutics|April 20, 2013
DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphomaDongwei Li, Kirsten Achilles Poon, Shang-Fan Yu, et al.
The Journal of Biological Chemistry|July 26, 2019
Vitamin C-dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transitionTian Zhang, Ke Huang, Yanling Zhu, et al.
Nature Biotechnology|January 24, 2012
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesBen-Quan Shen, Keyang Xu, Luna Liu, et al.
Nature|June 17, 2026
Spatial distribution of the proteome in the human body and in cancersLiang Yue, Wenhao Jiang, Sainan Li, et al.
Pageof 20